Journal article
Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse
The American journal of pathology, v 175(3), pp 1148-1159
Sep 2009
PMID: 19661443
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
The prevalence of human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) that result from HIV infection of the central nervous system is increasing. Macrophages, the primary target for HIV within the central nervous system, play a central role in HIV-induced neuropathogenesis. Drug abuse exacerbates HAND, but the mechanism(s) by which this increased neuropathology results in more severe forms of HAND in HIV-infected drug abusers is unclear. The addictive and reinforcing effects of many drugs of abuse, such as cocaine and methamphetamine, are mediated by increased extracellular dopamine in the brain. We propose a novel mechanism by which drugs of abuse intensify HIV neuropathogenesis through direct effects of the neurotransmitter dopamine on HIV infection of macrophages. We found that macrophages express dopamine receptors 1 and 2, and dopamine activates macrophages by increasing ERK 1 phosphorylation. Our results demonstrate for the first time that dopamine increases HIV replication in human macrophages and that the mechanism by which dopamine mediates this change is by increasing the total number of HIV-infected macrophages. This increase in HIV replication is mediated by activation of dopamine receptor 2. These findings suggest a common mechanism by which drugs of abuse enhance HIV replication in macrophages and indicate that the drug abuse-heightened levels of central nervous system dopamine could increase viral replication, thereby accelerating the development of HAND.
Metrics
Details
- Title
- Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse
- Creators
- Peter J Gaskill - Albert Einstein College of MedicineTina M Calderon - Albert Einstein College of MedicineAimée J Luers - Albert Einstein College of MedicineEliseo A Eugenin - Albert Einstein College of MedicineJonathan A Javitch - Columbia UniversityJoan W Berman - Albert Einstein College of Medicine
- Publication Details
- The American journal of pathology, v 175(3), pp 1148-1159
- Grant note
- T32 NS007098 / NINDS NIH HHS R01 DA025567 / NIDA NIH HHS R01 MH054137 / NIMH NIH HHS AI-051519 / NIAID NIH HHS F32DA024965 / NIDA NIH HHS NS07098 / NINDS NIH HHS MH083497 / NIMH NIH HHS MH05679 / NIMH NIH HHS DA022413 / NIDA NIH HHS P30 AI051519 / NIAID NIH HHS K05 DA022413 / NIDA NIH HHS K01 MH076679 / NIMH NIH HHS F32 DA024965 / NIDA NIH HHS MH054137 / NIMH NIH HHS MH076679 / NIMH NIH HHS DA025567 / NIDA NIH HHS
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- College of Medicine; Pharmacology and Physiology; Drexel University
- Web of Science ID
- WOS:000269623300021
- Scopus ID
- 2-s2.0-70349237001
- Other Identifier
- 991020100198204721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pathology